{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:54:40Z","timestamp":1761544480131,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.japh.2020.06.030","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T02:32:06Z","timestamp":1596162726000},"page":"e100-e104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacists are key in interpreting clinical implications of N-nitrosodimethylamine contamination in medications"],"prefix":"10.1016","volume":"60","author":[{"given":"Andrea V.","family":"Eads","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.japh.2020.06.030_bib1","first-page":"321","article-title":"Formation and metabolism of N-nitrosamines","volume":"7","author":"Rostkowska","year":"1998","journal-title":"Pol J Environ Stud"},{"key":"10.1016\/j.japh.2020.06.030_bib3","unstructured":"Bartsch H, O\u2019Neill IK, Schulte-Hermann R. Relevance of N-nitroso compounds to human cancer: exposures and mechanisms. Proceedings of the IXth International Symposium on N-nitroso Compounds, September 1\u20135, 1987; Baden Austria. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Scientific-Publications\/The-Relevance-Of-N-Nitroso-Compounds-To-Human-Cancer-Exposures-And-Mechanisms-1987. Accessed May 15, 2020."},{"author":"Liteplo","key":"10.1016\/j.japh.2020.06.030_bib4"},{"issue":"3","key":"10.1016\/j.japh.2020.06.030_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5487\/TR.2015.31.3.279","article-title":"Distribution of seven N-nitrosamines in food[published correction appears in Toxicol Res. 2018;34(4):371]","volume":"31","author":"Park","year":"2015","journal-title":"Toxicol Res"},{"issue":"5","key":"10.1016\/j.japh.2020.06.030_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/109287503768335896","article-title":"N-nitrosodimethylamine (NDMA) as a drinking water contaminant: a review","volume":"20","author":"Mitch","year":"2003","journal-title":"Environ Eng Sci"},{"key":"10.1016\/j.japh.2020.06.030_bib16","unstructured":"U.S. Food and Drug Administration. FDA alerts patients and health care professionals to nitrosamine impurity findings in certain metformin extended-release products. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-alerts-patients-and-health-care-professionals-nitrosamine-impurity-findings-certain-metformin. Accessed May 29, 2020;\u00a02020."},{"key":"10.1016\/j.japh.2020.06.030_bib17","unstructured":"Agency for Healthcare Research and Quality. Number of people with purchase in thousands by therapeutic class, United States, 1996\u20132017. Medical Expenditure Panel Survey. Generated Interactively: May 28 2020."},{"key":"10.1016\/j.japh.2020.06.030_bib18","doi-asserted-by":"crossref","first-page":"k3851","DOI":"10.1136\/bmj.k3851","article-title":"Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products\u00a0and risk of cancer: Danish nationwide cohort study","volume":"362","author":"Potteg\u00e5rd","year":"2018","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.japh.2020.06.030_bib20","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1021\/es500997e","article-title":"Formation mechanism of NDMA from ranitidine, trimethylamine, and other tertiary amines during chloramination: a computational study","volume":"48","author":"Liu","year":"2014","journal-title":"Environ Sci Technol"},{"issue":"6","key":"10.1016\/j.japh.2020.06.030_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/carcin\/bgw034","article-title":"Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine","volume":"37","author":"Zeng","year":"2016","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.japh.2020.06.030_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/gerona\/glv013","article-title":"Polypharmacy among adults aged 65 years and older in the United States: 1988\u20132010","volume":"70","author":"Charlesworth","year":"2015","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120303204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120303204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:50:00Z","timestamp":1761544200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120303204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1544319120303204"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.030","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacists are key in interpreting clinical implications of N-nitrosodimethylamine contamination in medications","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}